Changjiang Pharmaceutical Group Subsidiary Faces Bankruptcy Reorganization Filing

MT Newswires Live

2025/02/14

Changjiang Pharmaceutical Group (SHE:300391) said its subsidiary, Hubei Changjiang Xing Pharmaceutical, filed for bankruptcy reorganization by creditor Wuhan Century Baima System Engineering due to overdue debt of 6.2 million yuan, according to a Thursday filing with the Shenzhen Bourse.

The Shiyan Intermediate People's Court accepted the case on Feb. 11. The company is also undergoing pre-restructuring. Changjiang Xing plays a key role in the company's operations, and a successful restructuring could help resolve financial difficulties.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2511632723"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511632723\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2511632723?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-14 15:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511632723","market":"sg","top_or_hot":-1,"title":"Changjiang Pharmaceutical Group Subsidiary Faces Bankruptcy Reorganization Filing","media":"MT Newswires Live","content":"<html><body><p> Changjiang Pharmaceutical Group (SHE:300391) said its subsidiary, Hubei Changjiang Xing Pharmaceutical, filed for bankruptcy reorganization by creditor Wuhan Century Baima System Engineering due to overdue debt of 6.2 million yuan, according to a Thursday filing with the Shenzhen Bourse.</p><p>The Shiyan Intermediate People's Court accepted the case on Feb. 11. The company is also undergoing pre-restructuring. Changjiang Xing plays a key role in the company's operations, and a successful restructuring could help resolve financial difficulties.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Changjiang Pharmaceutical Group Subsidiary Faces Bankruptcy Reorganization Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChangjiang Pharmaceutical Group Subsidiary Faces Bankruptcy Reorganization Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-14 15:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Changjiang Pharmaceutical Group (SHE:300391) said its subsidiary, Hubei Changjiang Xing Pharmaceutical, filed for bankruptcy reorganization by creditor Wuhan Century Baima System Engineering due to overdue debt of 6.2 million yuan, according to a Thursday filing with the Shenzhen Bourse.</p><p>The Shiyan Intermediate People's Court accepted the case on Feb. 11. The company is also undergoing pre-restructuring. Changjiang Xing plays a key role in the company's operations, and a successful restructuring could help resolve financial difficulties.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2511632723","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2511632723","pubTimestamp":1739516520,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Changjiang Pharmaceutical Group  said its subsidiary, Hubei Changjiang Xing Pharmaceutical, filed for bankruptcy reorganization by creditor Wuhan Century Baima System Engineering due to overdue debt of 6.2 million yuan, according to a Thursday filing with the Shenzhen Bourse.The Shiyan Intermediate People's Court accepted the case on Feb. 11. The company is also undergoing pre-restructuring. Changjiang Xing plays a key role in the company's operations, and a successful restructuring could help resolve financial difficulties.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300391":"*ST长药","BK0028":"国家队","BK0224":"电气机械","BK0086":"举牌","BK0077":"质押式回购"},"translate_title":"长江药业集团子公司面临破产重整备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300391":0.9},"content_text":"Changjiang Pharmaceutical Group (SHE:300391) said its subsidiary, Hubei Changjiang Xing Pharmaceutical, filed for bankruptcy reorganization by creditor Wuhan Century Baima System Engineering due to overdue debt of 6.2 million yuan, according to a Thursday filing with the Shenzhen Bourse.The Shiyan Intermediate People's Court accepted the case on Feb. 11. The company is also undergoing pre-restructuring. Changjiang Xing plays a key role in the company's operations, and a successful restructuring could help resolve financial difficulties.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}